Target intelligence / Profile preview

TNKS2 divergent transcript (TNKS2-DT)

Target
TNKS2-DT
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

TNKS2 divergent transcript (TNKS2-DT, also known as TNKS2-AS1 or TNKS2 antisense RNA 1 (head to head)), is a long non-coding RNA (lncRNA) gene located on human chromosome 10. It does not code for a protein and currently has no established function, recognized disease association, or validation as a therapeutic target. It is sometimes included in lncRNA catalogs, but there is no evidence to support its role as a receptor, enzyme, transporter, or drug target. Key distinctions: - This gene should not be confused with TNKS2 (Tankyrase 2), which is a well-characterized poly(ADP-ribose) polymerase family enzyme and a recognized therapeutic target. TNKS2-DT is an RNA transcript associated with, but distinct from, the protein-coding TNKS2 gene. - The current literature and gene databases do not document any direct functional, biomarker, or therapeutic role for TNKS2-DT. Summary: TNKS2 divergent transcript (TNKS2-DT) is a cataloged human lncRNA with limited biological characterization and no current application as a therapeutic target, biomarker, or subject of drug interaction studies.

Other names
TNKS2-AS1TNKS2 antisense RNA 1 (head to head)TNKS2-DT
02

Biological functions

Unknown; lncRNA functions are sometimes involved in gene regulation but no specific function documented for TNKS2-DT
03

Disease associations

No clearly established disease roles or clinical implications are reported in current databases for TNKS2-DT

Beyond the preview

Go deeper on TNKS2 divergent transcript (TNKS2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNKS2 divergent transcript (TNKS2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call